---
$id: https://graph.org.ai/products/commodity/51343309
$type: Product
source: UNSPSC
code: "51343309"
title: "Viroxime"
class: "51343300"
classTitle: "Antivirals, synthesized"
family: "51340000"
familyTitle: "Antiviral drugs"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Viroxime

**UNSPSC Code**: 51343309
**Class**: [Antivirals, synthesized](Antivirals, synthesized.mdx)
**Family**: [Antiviral drugs](../Antiviral drugs.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

This classification denotes an antiviral agent with the molecular formula (C17H18N4O3S)2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier I5V34WG2BE, more generally known as viroxime. European Medicines Agency schedules viroxime in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB00082MIG. The term VIROXIME is an International Non-Proprietary Name or INN. VIROXIME is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule viroxime under HS 29350090 and SITC 51580. As of Q4 2014, VIROXIME remains the US FDA Preferred Term for this commodity. SMILES: CC(C)S(=O)(=O)N1C2=C(C=CC(=C2)C(=NO)C3=CC=CC=C3)N=C1N.

